Impact of Dietary Inflammatory Potential on Breast Cancer Risk
Longitudinal Study Evaluating the Impact of Dietary Inflammatory Potential on Breast Cancer Risk in a Cohort of Women Followed in the Breast Cancer Prevention Clinic at the Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute
Sponsor: Ohio State University Comprehensive Cancer Center
This observational or N/A phase trial investigates Breast Atypical Ductal Hyperplasia and Breast Atypical Lobular Hyperplasia and is currently actively recruiting participants. Ohio State University Comprehensive Cancer Center leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
5 versions recorded-
Mar 2025 — Present [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Sep 2024 — Mar 2025 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
-
Oct 2023 — Jul 2024 [monthly]
Not Yet Recruiting
-
Feb 2022 — Oct 2023 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ohio State University Comprehensive Cancer Center
For direct contact, visit the study record on ClinicalTrials.gov .